Cargando…
Evaluation of the new 2.0 version of the Roche SARS-CoV-2 Rapid Antigen Test
We evaluated the new 2.0 version of the Roche Diagnostics SARS-CoV-2 Rapid Antigen Test (RAT 2.0) for the detection of SARS-CoV-2. Our evaluation material comprised of nasopharyngeal samples of 140 persons positive for SARS-CoV-2 nucleic acid amplification test (NAAT) and of 100 persons negative for...
Autores principales: | Flinck, Heini, Aittoniemi, Janne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228153/ https://www.ncbi.nlm.nih.gov/pubmed/37263352 http://dx.doi.org/10.1016/j.jviromet.2023.114758 |
Ejemplares similares
-
Evaluation of the Roche-SD Biosensor rapid antigen test: Antigen is not reliable in detecting SARS-CoV-2 at the early stage of infection with respiratory symptoms
por: Flinck, Heini, et al.
Publicado: (2022) -
Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19
por: Flinck, Heini, et al.
Publicado: (2021) -
The Roche Cancer Genome Database 2.0
por: Küntzer, Jan, et al.
Publicado: (2011) -
Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests
por: Batty, Mitchell, et al.
Publicado: (2023) -
Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands
por: Iglὁi, Zsὁfia, et al.
Publicado: (2021)